Literatura académica sobre el tema "General Unknown Screening"

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "General Unknown Screening".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "General Unknown Screening"

1

Böhme. "Improved “General Unknown” Drug Screening Using GCxGCqMS." Scientia Pharmaceutica 77, no. 1 (2009): 183. http://dx.doi.org/10.3797/scipharm.oephg.21.sl-16.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Lowres, Nicole, Lis Neubeck, Julie Redfern, and S. Ben Freedman. "Screening to identify unknown atrial fibrillation." Thrombosis and Haemostasis 110, no. 08 (2013): 213–22. http://dx.doi.org/10.1160/th13-02-0165.

Texto completo
Resumen
SummaryAtrial fibrillation (AF) is associated with a significantly increased stroke risk which is highly preventable with appropriate oral anticoagulant therapy (OAC). However, AF may be asymptomatic and unrecognised prior to stroke. We aimed to determine if single time-point screening for AF could identify sufficient numbers with previously undiagnosed AF, to be effective for stroke prevention. This is a systematic review of clinical trials, by searching electronic medical databases, reference lists and grey literature. Studies were included if they evaluated a general ambulant adult population, using electrocardiography or pulse palpation to identify AF. We identified 30 individual studies (n=122,571, mean age 64 years, 54% male) in nine countries. Participants were recruited either from general practitioner and outpatient clinics (12 studies) or population screening/community advertisements (18 studies). Prevalence of AF across all studies was 2.3% (95% CI, 2.2–2.4%), increasing to 4.4% (CI, 4.1–4.6%) in those ≥65 years (16 studies, n= 27,884). Overall incidence of previously unknown AF (14 studies, n=67,772) was 1.0% (CI, 0.89–1.04%), increasing to 1.4% (CI, 1.2–1.6%) in those ≥65 years (8 studies, n= 18,189) in whom screening setting did not influence incidence identified. Of those with previously unknown AF, 67% were at high risk of stroke. Screening can identify 1.4% of the population ≥65 years with previously undiagnosed AF. Many of those identified would be eligible for, and benefit from OAC to prevent stroke. Given this incidence, community AF screening strategies in at risk older age groups could potentially reduce the overall health burden associated with AF.
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Richeval, C., J. F. Wiart, L. Humbert, M. Shbair, and M. Lhermitte. "General unknown screening of xenobiotics: the contribution of an acidic extraction." Annales de Toxicologie Analytique 23, no. 3 (2011): 119–24. http://dx.doi.org/10.1051/ata/2011120.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Sukumaran, NimishaPulikkal, and RHiranmai Yadav. "General unknown screening, antioxidant and anti-inflammatory potential of Dendrobium macrostachyum Lindl." Ancient Science of Life 35, no. 4 (2016): 240. http://dx.doi.org/10.4103/0257-7941.188181.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Duretz, B., S. Robinson, S. Scurati, E. Genin, and D. Lamiable. "General unknown screening of illicit drugs: A novel approach using high resolution and accurate mass." Toxicology Letters 196 (July 2010): S291—S292. http://dx.doi.org/10.1016/j.toxlet.2010.03.920.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

Marquet, P., N. Venisse, É. Lacassie, and G. Lachâtre. "In-source CID mass spectral libraries for the “general unknown” screening of drugs and toxicants." Analusis 28, no. 10 (2000): 925–34. http://dx.doi.org/10.1051/analusis:2000280925.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Köppel, C., and J. Tenczer. "Scope and limitations of a general unknown screening by gas chromatography—mass spectrometry in acute poisoning." Journal of the American Society for Mass Spectrometry 6, no. 11 (1995): 995–1003. http://dx.doi.org/10.1016/1044-0305(95)00585-4.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Sauvage, François-Ludovic, Nicolas Picard, Franck Saint-Marcoux, Jean-Michel Gaulier, Gérard Lachâtre, and Pierre Marquet. "General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: Applications and constraints." Journal of Separation Science 32, no. 18 (2009): 3074–83. http://dx.doi.org/10.1002/jssc.200900092.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

Picard, Nicolas, Dorra Dridi, François-Ludovic Sauvage, Naceur A. Boughattas, and Pierre Marquet. "General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase I metabolism." Journal of Separation Science 32, no. 13 (2009): 2209–17. http://dx.doi.org/10.1002/jssc.200900099.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Tos, Tina, Helle Klyver, and Krzysztof T. Drzewiecki. "Extensive screening for primary tumor is redundant in melanoma of unknown primary." Journal of Surgical Oncology 104, no. 7 (2011): 724–27. http://dx.doi.org/10.1002/jso.21994.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía